Cogent Biosciences Balance Sheet (2017-2026) | COGT

Balance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter)
0.56M1.40M3.67M6.12M8.68M
Receivables - Doubtful (Quarter)
46.69M89.54M157.07M
Assets
Current Assets
Cash & Equivalents (Quarter)
202.89M219.68M191.05M325.56M140.57M139.89M160.70M214.32M86.81M53.23M215.80M88.22M97.05M98.17M126.00M127.60M125.30M312.01M241.21M181.17M
Receivables - Net (Quarter)
Receivables (Quarter)
Prepaid Assets (Quarter)
4.62M2.95M3.69M3.86M6.07M4.43M4.75M5.12M6.91M5.06M6.16M6.75M6.01M9.39M7.22M7.16M6.35M9.59M11.43M12.52M
Current Assets (Quarter)
207.50M222.63M194.73M330.68M296.42M264.97M226.27M334.52M285.95M270.77M441.90M369.97M341.53M296.47M252.88M245.01M397.24M910.36M877.80M804.82M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
1.34M1.71M2.08M3.59M6.54M7.78M9.03M9.10M8.64M8.34M7.82M7.36M7.02M6.47M6.45M5.85M5.27M5.46M5.30M4.78M
Long-Term Investments (Quarter)
21.51M33.79M7.46M26.69M10.03M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)
2.04M1.25M5.61M4.89M4.77M4.75M4.78M4.78M4.86M4.86M4.86M4.86M4.86M4.86M4.86M4.86M4.49M0.42M1.94M1.94M
Non-Current Assets (Quarter)
7.88M9.46M12.14M35.38M35.14M35.84M36.93M57.85M69.49M42.67M34.21M59.96M42.49M31.43M30.91M29.81M28.69M27.25M25.20M29.73M
Assets (Quarter)
215.38M232.09M206.87M366.05M331.56M300.81M263.20M392.37M355.45M313.44M476.11M429.94M384.02M327.90M283.80M274.82M425.93M937.61M903.01M834.55M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.35M3.48M4.01M3.49M4.09M5.84M4.17M7.16M9.87M10.65M15.56M8.97M15.06M12.01M14.15M16.62M16.03M9.50M13.74M7.49M
Payables (Quarter)
4.35M3.48M4.01M3.49M4.09M5.84M4.17M7.16M9.87M10.65M15.56M8.97M15.06M12.01M14.15M16.62M16.03M9.50M13.74M7.49M
Accumulated Expenses (Quarter)
2.05M3.39M1.45M3.16M4.07M17.88M16.00M17.42M5.87M9.87M2.43M5.68M7.73M42.13M3.67M8.13M10.50M15.74M6.20M50.32M
Other Accumulated Expenses (Quarter)
0.23M0.23M0.25M1.56M1.20M0.40M1.01M0.50M0.46M0.44M0.64M0.25M0.31M0.37M0.48M1.27M1.28M6.75M1.85M1.32M
Current Leases (Quarter)
2.25M2.32M2.40M9.06M2.01M1.42M0.95M1.18M1.34M1.39M1.43M1.48M1.52M1.56M1.61M1.66M1.71M1.55M1.38M1.49M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)
16.71M17.08M17.88M27.66M23.55M26.85M21.12M25.76M34.72M38.17M36.69M40.00M53.05M55.71M49.32M58.42M62.25M63.95M57.98M59.30M
Non-Current Liabilities
Non-Current Debt (Quarter)
43.95M44.25M
Convertible Debt (Quarter)
222.90M223.17M223.46M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
85.40M
Operating Leases (Quarter)
1.44M0.83M1.13M19.01M18.07M18.23M18.52M18.18M17.83M17.47M17.09M16.71M16.31M15.90M15.48M15.05M14.60M14.36M14.10M19.32M
Other Non-Current Liabilities (Quarter)
3.06M1.70M0.01M2.36M2.37M0.03M0.06M0.09M
Total Non-Current Liabilities (Quarter)
14.85M43.38M71.61M64.80M117.42M121.10M301.20M295.25M302.07M
Total Liabilities (Quarter)
18.15M17.91M19.01M46.67M41.62M45.08M39.63M43.94M52.55M55.63M53.78M56.71M69.36M71.61M64.80M119.78M123.47M301.24M295.31M302.16M
Shareholder's Equity
Total Debt (Quarter)
43.95M44.25M
Common Equity (Quarter)
197.24M214.18M187.86M319.38M289.94M255.74M223.56M348.43M302.90M257.80M422.33M373.22M314.66M256.29M219.00M155.04M302.46M636.37M607.69M532.39M
Liabilities and Shareholders Equity (Quarter)
215.38M232.09M206.87M366.05M331.56M300.81M263.20M392.37M355.45M313.44M476.11M429.94M384.02M327.90M283.80M274.82M425.93M937.61M903.01M834.55M
Retained Earnings (Quarter)
-246.10M-270.97M-301.61M-336.50M-0.16M-411.21M0.02M-0.10M-549.26M0.25M-661.97M-0.19M-791.56M0.45M-931.47M-1005.00M-1085.93M0.35M-1285.80M-1382.20M
Preferred Shares (Quarter)
85.40M78.40M71.40M65.83M65.83M62.31M62.31M60.03M60.03M162.12M60.03M54.09M54.09M54.08M53.83M53.83M53.83M35.56M35.56M
Treasury Shares (Quarter)
0.10M0.10M0.10M2.50M0.08M0.54M